Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuzuka Kanno"'
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Chemotherapy resistance is a huge barrier for head and neck cancer (HNC) patients and therefore requires close attention to understand its underlay mechanisms for effective strategies. In this review, we first summarize the molecular mechanisms of ch
Externí odkaz:
https://doaj.org/article/a5f977622fd04b5283e06c2dde17dd4f
Autor:
Kouji Matsushima, Shiro Shibayama, Tatsuro Ogawa, Hiroyasu Aoki, Yuzuka Kanno, Shungo Deshimaru, Haru Ogiwara, Joost J. Oppenheim, De Yang, Shoji Yokochi, Shigeyuki Shichino, Yoshiro Ishiwata, Satoshi Ueha, Chang-Yu Chen
The expansion of intratumoral stem-like/progenitor exhausted CD8+ T (Tstem/Tpex) cells provides a potential approach to improve the therapeutic efficacy of immune checkpoint blockade (ICB). Thus, here we demonstrate a strategy to facilitate Tstem/Tpe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c68af7bd2adb3ecdb017878aeb93bc4
https://doi.org/10.1158/2326-6066.c.6550191
https://doi.org/10.1158/2326-6066.c.6550191
Autor:
Kouji Matsushima, Shiro Shibayama, Tatsuro Ogawa, Hiroyasu Aoki, Yuzuka Kanno, Shungo Deshimaru, Haru Ogiwara, Joost J. Oppenheim, De Yang, Shoji Yokochi, Shigeyuki Shichino, Yoshiro Ishiwata, Satoshi Ueha, Chang-Yu Chen
Supplementary Figures 1-5 and Supplementary table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57412bcc6d7812a93ce9b1841a5fc87f
https://doi.org/10.1158/2326-6066.22543263
https://doi.org/10.1158/2326-6066.22543263
Autor:
Tatsuro Ogawa, Shiro Shibayama, De Yang, Haru Ogiwara, Hiroyasu Aoki, Yuzuka Kanno, Joost J. Oppenheim, Yoshiro Nagakute Aza-arata Ishiwata, Shoji Yokochi, Kouji Matsushima, Shungo Deshimaru, Chang Yu Chen, Shigeyuki Shichino, Satoshi Ueha
Publikováno v:
Cancer Immunol Res
The expansion of intratumoral stem-like/progenitor exhausted CD8+ T (Tstem/Tpex) cells provides a potential approach to improve the therapeutic efficacy of immune checkpoint blockade (ICB). Thus, here we demonstrate a strategy to facilitate Tstem/Tpe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e788cb6adb2153bc63e4758e407aa2b9
https://doi.org/10.1158/2326-6066.cir-21-0265
https://doi.org/10.1158/2326-6066.cir-21-0265
Autor:
Yoshiro Ishiwata, Chang Yu Chen, Joost J. Oppenheim, Tatsuro Ogawa, Shiro Shibayama, Haru Ogiwara, De Yang, Shungo Deshimaru, Yuzuka Kanno, Satoshi Ueha, Koji Matsushima, Shigeyuki Shichino, Shoji Yokochi
BackgroundThe expansion of intratumoral stem-like CD8+ T (Tstem) cells provides a potential approach to improving the therapeutic efficacy of immune checkpoint blockade (ICB). Thus, here we demonstrate a strategy to facilitate Tstem cell expansion by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::801358abc60a0c99cb74029ecba843aa
https://doi.org/10.1101/2020.12.15.422990
https://doi.org/10.1101/2020.12.15.422990
Autor:
Ann-Joy Cheng, Long Sheng Lu, Chang Yu Chen, Yuzuka Kanno, Meng Yu Lai, Lai Lei Ting, Jeng Fong Chiou, Hsin Lun Lee, Guo Rung You, Yin Ju Chen
Publikováno v:
Cancers, Vol 12, Iss 3482, p 3482 (2020)
Cancers
Volume 12
Issue 11
Cancers
Volume 12
Issue 11
Cisplatin is the first-line chemotherapy agent for head and neck cancer (HNC), but its therapeutic effects are hampered by its resistance. In this study, we employed systemic strategies to overcome cisplatin resistance (CR) in HNC. CR cells derived f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fa2c9d21504db7749be947c7d60f88d
https://www.mdpi.com/2072-6694/12/11/3482
https://www.mdpi.com/2072-6694/12/11/3482